CYH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: the trend is still bearish (SMA_200 > SMA_20 > SMA_5) and momentum is not turning convincingly.", "Near-term event risk is high with Q4/FY2025 earnings on 2026-02-19 (after hours) and an EPS estimate of -0.32; for an impatient buyer this makes the current entry unattractive.", "Positive debt-reduction news helps the story, but it\u2019s not yet showing up as a sustained technical reversal; better to wait for a reclaim of key levels (above ~3.22 pivot, ideally >3.44)."]
["Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5), implying rallies are likely to face selling pressure.", "Momentum: MACD histogram -0.00516 (below zero) and only slightly contracting\u2014bearish momentum is easing but not flipped bullish.", "RSI(6)=46.26: neutral, consistent with sideways-to-down consolidation rather than a strong reversal.", "Key levels: Pivot 3.223 (price 3.175 is below it). Support S1 3.001 then S2 2.864. Resistance R1 3.444 then R2 3.581.", "Pattern-based odds: Similar-pattern analysis suggests modest upside bias (60% chance) but the expected moves are small near-term (+~1.75% next day), not strong enough to outweigh earnings risk."]
["Debt reduction: Redemption of $222.5M senior secured notes, reducing debt to ~$1.78B and improving financial flexibility (supportive for equity).", "Upcoming earnings (2026-02-19): A better-than-feared print or guidance could trigger a short-term relief rally given the low price level."]
can open a move toward ~2.86 (S2).", "Sector/analyst concern: Wells Fargo highlights a tougher hospital backdrop into 2026 as tailwinds fade and legislative risk rises."]
["Latest reported quarter: 2025/Q3.", "Revenue: $3.087B, down -0.10% YoY (flat-to-slightly down top-line trend).", "Profitability: Net income $130M, down -133.25% YoY; EPS 0.96, down -132.54% YoY (sharp deterioration vs prior year).", "Margin: Gross margin 81.6%, up +0.69% YoY (slight improvement, but not enough to offset the earnings decline)."]
["Recent changes are mixed: Truist raised PT to $4.50 (Hold) on 2026-01-05, while Wells Fargo cut PT to $2 (Underweight) on 2026-01-07.", "Wall Street pros: Potential operating backdrop support/demand trends (Truist) and balance-sheet improvement from debt paydown.", "Wall Street cons: Concern about 2026 hospital headwinds and policy/legislative risks; Wells remains underweight with a materially lower target.", "Positioning/behavioral checks: Hedge funds neutral, insiders neutral; no recent Congress trading data available (no notable political/influential buying/selling signal).", "Intellectia Proprietary Trading Signals: No signal on given stock today (AI Stock Picker: none; SwingMax: none), so there is no model-driven reason to force an immediate entry."]
